FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Pine Pharmaceuticals Tropi-Phen Recall

Tropi-Phen (tropicamide 1%, phenylephrine 2

Pine Pharmaceuticals, LLC · Tonawanda, NY

Risk level
Class II
Reported by FDA
Oct 25, 2023
Recall ID
D-0063-2024
Check your lot numberHow we source this data

Summary

Pine Pharmaceuticals recalled Tropi-Phen starting Oct 2, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0063-2024 on Oct 25, 2023. Reason: Lack of Assurance of Sterility. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility

Product description

Tropi-Phen (tropicamide 1%, phenylephrine 2.5%) ophthalmic solution, 5mL multi-use dropper, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

Lot numbers, UPCs & expiration codes

Lot #: 67659, Exp. Date 10/16/2023; 70316, Exp. Date 1/30/2024

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0063-2024
Classification
Class II
Status
Terminated
Recall initiated
Oct 2, 2023
FDA report date
Oct 25, 2023
Quantity
662 dropper
Recall type
Voluntary: Firm initiated
Recalling firm
Pine Pharmaceuticals, LLC

Original FDA data

Every field from FDA enforcement report D-0063-2024, exactly as published.

Show all FDA fields
City
Tonawanda
State
NY
Status
Terminated
Country
United States
Event ID
93154
Address
355 Riverwalk Pkwy
Code information
Lot #: 67659, Exp. Date 10/16/2023; 70316, Exp. Date 1/30/2024
Postal code
14150-5837
Report date
Oct 25, 2023
Product type
Drugs
Recall number
D-0063-2024
Classification
Class II
Recalling firm
Pine Pharmaceuticals, LLC
Product quantity
662 dropper
Termination date
May 15, 2024
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
Tropi-Phen (tropicamide 1%, phenylephrine 2.5%) ophthalmic solution, 5mL multi-use dropper, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
Distribution pattern
Nationwide within the United States
Recall initiation date
Oct 2, 2023
Initial firm notification
Letter
Center classification date
Oct 19, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0063-2024, published Oct 25, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls